Free · 13,587 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

The importance of power in photobiomodulation: a systematic review and meta-analysis of high-intensity laser therapy

Class IV high-intensity laser therapy appears effective and safe for durable pain reduction across deep-tissue musculoskeletal pathologies, supporting its recognition in clinical practice and coverage by payers as a valuable therapeutic option.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors report a systematic review and meta-analysis of 105 Class IV high-intensity laser therapy (HILT) studies, mostly on deep-tissue musculoskeletal conditions. They found large pain reductions in randomized trials, no serious adverse events reported, and greater pain reduction than low-level laser therapy in comparative trials. Limits stated include the need for further multicenter trials to refine protocols.

Studies included
105
Who or what was studied
Patients with deep-tissue musculoskeletal and other conditions treated with Class IV high-intensity laser therapy in trials published 2018 to April 2026; the abstract reports 2,710 HILT and 2,925 control participants.
Limits stated in the abstract
The abstract states that further multicenter trials are needed to refine treatment protocols.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Introduction

Low-level laser therapy (LLLT; ≤ 0.5 W) is guideline-recommended in the United States for shallow-tissue oral mucositis and other superficial pathologies but has generally failed in trials for deeper tissue conditions due to limited penetration and subtherapeutic dosing. By contrast, Class IV high-intensity laser therapy (HILT; ≥ 0.5-80 W), typically at ∼100-fold higher power, has proven successful for many of these deeper tissue indications.

Methods

We systematically searched PubMed, Google Scholar, and the Cochrane Database for Class IV HILT trials published from 2018 to April 2026, classifying interventions as effective when they showed large effect sizes (Cohen's d > 0.8).

Results

Across 105 included studies (n = 2,710 HILT; n = 2,925 controls), no serious adverse events were reported. HILT reduced pain in all randomized trials of knee (k = 27), spine/neuromuscular (k = 20), shoulder/arm (k = 20), and wounds (k = 2), with > 90% showing large effect sizes. Additional benefits were observed in disorders of the feet (k = 13), hand/wrist (k = 8), face/jaw (k = 7), osteoporosis (k = 2), endometriosis, coronary artery disease, cognitive impairment, fibromyalgia, COVID-19, and obesity. HILT yielded durable analgesia, with large VAS pain reductions at end of treatment, < 3-month, and ≥ 3-month follow-ups (SMD -0.98, -1.18, and -1.01; k = 50, 19, and 21, respectively). Functional outcomes improved consistently, including range of motion (92%; k = 26), functional performance (84%; k = 57), and quality of life (85%; k = 25). Structural and physiological changes were observed, including increased knee cartilage thickness, reduced rotator cuff tear size, weight loss, and improved nerve conduction. Comparative trials showed HILT produced greater pain reduction than LLLT in 13/13 studies, all with large effect sizes. Mean HILT power was 9.3 W (median 10.0; range 0.5-30), and mean power density was 19.5 W/cm2 (median 10; range 0.1-52.5).

Conclusion

Class IV high-intensity laser therapy appears effective and safe for durable pain reduction across deep-tissue musculoskeletal pathologies, supporting its recognition in clinical practice and coverage by payers as a valuable therapeutic option. Further multicenter trials are needed to refine treatment protocols. SYSTEMATIC REVIEW

Registration

https://www.crd.york.ac.uk/PROSPERO/view/CRD420251021772, identifier CRD420251021772.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Power
0.5 W, 80 W, 9.3 W

How to read a review: what to check before relying on this kind of research.

Terms in this paper: High-intensity laser therapy, Laser, Systematic review, Photobiomodulation, Meta-analysis, Low-level laser therapy, Visual analogue scale, Oral mucositis. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies